Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-16 · accession 0001209191-23-046148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-16 | 2023-08-16 | TSHA | Donenberg Phillip B. | Dir | P - Purchase | $0.9 | +111.1K | 114.1K | +3,704% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | P | A | 111,111 | $0.9 | 114,111 | D | — | — |